Molecular Genetic Testing of Hemostasis and Thrombosis in Developing Countries: Achievements, Hopes, and Challenges

ABSTRACT

In today's developing world, how do we define a “developing country”? What level of effort and resources is invested in diagnosis, patient care, and research in those countries that we define to be developing? In particular, what is the situation with respect to molecular genetic testing in these countries? How much has been achieved to date, and what are the challenges to further achievements? This article describes the current status, challenges, and future hopes with respect to molecular genetic testing in hemostasis and thrombosis from the perspective of experts from three countries: Brazil, Colombia, and Iran. These individuals have lived and practiced genetic testing in their countries and have also had the experience to work and/or interact with the developed world to enable an appreciation of the difference.

KEYWORDS

Developing countries - genetic testing - hemostasis - thrombosis

REFERENCES

• 1 Parra F C, Amado R C, Lambertucci J R, Rocha J, Antunes C M, Pena S DJ. Color and genomic ancestry in Brazilians.  Proc Natl Acad Sci U S A. 2003;  100 177-182
• 2 Roisenberg I, Morton N E. Genetic aspects of hemophilias A and B in Rio Grande do Sul, Brazil.  Hum Hered. 1971;  21 97-107
• 3 Camargo A A, Simpson A J. Collaborative research networks work.  J Clin Invest. 2003;  112 468-471
• 4 Simpson A J, Reinach F C, Arruda P et al.. The genome sequence of the plant pathogen Xylella fastidiosa. The Xylella fastidiosa Consortium of the Organization for Nucleotide Sequencing and Analysis.  Nature. 2000;  406 151-159
• 5 Arruda V R, Annichino-Bizzachi J M, Sonati M de F, Costa F F. Factor VIII and IX genes polymorphisms in a Brazilian black population.  Thromb Haemost. 1993;  70 371
• 6 da Silva Júnior W A, Figueiredo M S. Analysis of factor VIII gene polymorphisms in Brazilian blacks reveals further differences in the black population.  Hum Hered. 1994;  44 252-260
• 7 Figueiredo M S, Bowen D J, Silva Júnior W A, Zago M A. Factor IX gene haplotypes in Brazilian blacks and characterization of unusual DdeI alleles.  Br J Haematol. 1994;  87 789-796
• 8 Figueiredo M S, Tavella M H, Simões B P. Large DNA inversions, deletions, and TaqI site mutations in severe haemophilia A.  Hum Genet. 1994;  94 473-478
• 9 Arruda V R, Pieneman W C, Reitsma P H et al.. Eleven novel mutations in the factor VIII gene from Brazilian hemophilia A patients.  Blood. 1995;  86 3015-3020
• 10 Soares R P, Chamone D A, Bydlowski S P. Factor VIII gene inversions and polymorphisms in Brazilian patients with haemophilia A: carrier detection and prenatal diagnosis.  Haemophilia. 2001;  7 299-305
• 11 Figueiredo M S, Bowen D J, Silva Júnior W A, Zago M A. Factor IX gene haplotypes in Brazilian blacks and characterization of unusual DdeI alleles.  Br J Haematol. 1994;  87 789-796
• 12 Manno C S, Pierce G F, Arruda V R et al.. AAV-mediated, liver-directed gene transfer for severe hemophilia B: successful transduction and limitations imposed by the host immune response.  Nat Med. 2006;  12 342-347
• 13 Bertina R M, Koeleman B P, Koster T et al.. Mutation in blood coagulation factor V associated with resistance to activated protein C.  Nature. 1994;  369 64-67
• 14 Arruda V R, Annichino-Bizzacchi J M, Costa F F, Reitsma P H, Factor V. Leiden (FVQ 506) is common in a Brazilian population.  Am J Hematol. 1995;  49 242-243
• 15 Poort S R, Rosendaal F R, Reitsma P H, Bertina R M. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis.  Blood. 1996;  88 3698-3703
• 16 Arruda V R, Annichino-Bizzacchi J M, Gonçalves M S, Costa F F. Prevalence of the prothrombin gene variant (nt20210A) in venous thrombosis and arterial disease.  Thromb Haemost. 1997;  78 1430-1433
• 17 Pieroni F, Lourenço D M, Morelli V M, Maffei F H, Zago M A, Franco R F. Cytokine gene variants and venous thrombotic risk in the BRATROS (Brazilian Thrombosis Study).  Thromb Res. 2007;  120 221-229
• 18 Mello T B, Siqueira L H, Montavão S A, Ozello M C, Annichino-Bizzacchi J M. Low density lipoprotein receptor-related protein polymorphisms are not risk factors for venous thromboembolism.  Thromb Res. 2008;  121 625-629
• 19 de Paula Sabino A, Guimarães D A, Ribeiro D D et al.. Increased factor V Leiden frequency is associated with venous thrombotic events among young Brazilian patients.  J Thromb Thrombolysis. 2007;  24 261-266
• 20 Lourenço D M, Noguti M A, Juliano L. Antithrombin III dosage using the chromogenic substrate Tos-Gly-Pro-Arg-NAN, in several pathological situations.  Rev Assoc Med Bras. 1995;  41 373-378
• 21 Pugliese L, Arruda V R, Annichino-Bizzacchi J M. A novel nonsense mutation 6, E - X in the protein S gene causes type I deficiency.  Hum Hered. 1999;  49 121-122
• 22 Arnaldi L A, Polimeno N C, Arruda V R, Annichino-Bizzacchi J M. A novel splice site mutation in a Brazilian patient with hereditary antithrombin deficiency type I.  Hum Hered. 1999;  49 119-120
• 23 Singh Y S, Arruda V R, Ozello M C, Machado T F, Annichino-Bizzacchi M M. Identification of one novel and three other point mutations in the protein C gene of five unrelated Brazilian patients with hereditary protein C deficiency.  Haematologica. 2000;  85 891-893
• 24 Pan American Health Organization (PAHO) .Available at http://www.paho.org. Accessed August 7, 2008
• 25 Bedoya G, Montoya P, García J et al.. Admixture dynamics in Hispanics: a shift in the nuclear genetic ancestry of a South American population isolate.  Proc Natl Acad Sci U S A. 2006;  103 7234-7239
• 26 Liascovich R, Rittler M, Castilla E. Consanguinity in South América: demographic aspects.  Hum Hered. 2001;  51 27-34
• 27 Giraldo A. Genetic services in Colombia.  Community Genet. 2004;  7 126-129
• 28 Kosik K S, Lopera F. Genetic testing must recognize impact of bad news on recipient.  Nature. 2008;  454 158-159
• 29 Giraldo A, Gómez A, Salguero G et al.. MLH1 and MSH2 mutations in Colombian families with hereditary nonpolyposis colorectal cancer (Lynch syndrome)–description of four novel mutations.  Fam Cancer. 2005;  4 285-290
• 30 Gómez A, Salguero G, García H et al.. Detection mutations in the DNA mismatch repair genes of hMLH1 and hMSH2 genes in Colombian families with suspicion of hereditary non-polyposis colorectal carcinoma (Lynch syndrome).  Biomedica. 2005;  25 315-324
• 31 Heit J A, Thorland E C, Ketterling R P et al.. Germline mutations in Peruvian patients with hemophilia B: pattern of mutation in AmerIndians is similar to the putative endogenous germline pattern.  Hum Mutat. 1998;  11 372-376
• 32 Heit J A, Ketterling R P, Zapata R E et al.. Brandenberg-type promoter mutation.  Haemophilia. 1999;  5 73-75
• 33 Mulder K, Llinás A. The target joint.  Haemophilia. 2004;  10(Suppl 4) 152-156
• 34 Llinás A. The role of synovectomy in the management of a target joint.  Haemophilia. 2008;  14(Suppl 3) 177-180
• 35 Srivastava A, Rodeghiero F. Epidemiology of von Willebrand disease in developing countries.  Semin Thromb Hemost. 2005;  31 569-576
• 36 SSC Working Group on Factor VIII and Factor IX .Rare bleeding disorders minutes from the XXI I STH Congress 2007. Available at http://www.rbdd.org/minute-july07.htm Accessed August 6, 2008
• 37 Rahimi Z, Vaisi-Raigani A, Nagel R L, Muniz A. Thrombophilic mutations among southern Iranian patients with sickle cell disease: high prevalence of factor V Leiden.  J Thromb Thrombolysis. 2008;  25 288-292
• 38 Chegeni R, Kazemi B, Hajifathali A, Pourfathollah A A, Rastegar-Lari G. Factor V mutations in Iranian patients with activated protein C resistance and venous thrombosis.  Thromb Res. 2007;  119 189-193
• 39 Florell S R, Rodgers G M. Inherited thrombotic disorders: an update.  Am J Hematol. 1997;  54 53-60
• 40 Mannucci P M, Duga S, Peyvandi F. Recessively inherited coagulation disorders.  Blood. 2004;  104 1243-1252
• 41 Peyvandi F, Duga S, Akhavan S, Mannucci P M. Rare coagulation deficiencies.  Haemophilia. 2002;  8 308-321
• 42 Lak M, Peyvandi F, Mannucci P M. Clinical manifestations and complications of childbirth and replacement therapy in 385 Iranian patients with type 3 von willebrand disease.  Br J Haematol. 2000;  111 1236-1239
• 43 Afrasiabi A, Artoni A, Karimi M, Peyvandi F, Ashouri E, Mannucci P M. Glanzmann thrombasthenia and Bernard-Soulier syndrome in south of Iran.  Clin Lab Haematol. 2005;  27 324-327
• 44 Peyvandi F, Jayandharan G, Chandy M et al.. Genetic diagnosis of haemophilia and other inherited bleeding disorders.  Haemophilia. 2006;  12(Suppl) 82-89
• 45 Peyvandi F. Carrier detection and prenatal diagnosis of hemophilia in developing countries.  Semin Thromb Hemost. 2005;  31 544-554
• 46 Karimi M, Peyvandi F, Siboni S, Ardeshiri R, Gringeri A, Mannucci P M. Comparison of attitudes towards prenatal diagnosis and termination of pregnancy for haemophilia in Iran and Italy.  Haemophilia. 2004;  10 367-369
• 47 Hedayat K M, Shooshtarizadeh P, Raza M. Therapeutic abortion in Islam: contemporary views of Muslim Shiite scholars and effect of recent Iranian legislation.  J Med Ethics. 2006;  32 652-657